// App-Quantinova.ai

BSH19‐EP‐018 : Audit on NICE Technological Guidance regarding Azacitidine for high IPSS Myelodysplastic Syndrome

Researchers

Presenter

  • Z.J. Ang

Principal Investigators

  • A. Wood

  • B. Czako

Medical Centers

  • Rheumatology, Waterford Regional Hospital, Waterford, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Oncology (ONC)

Disease

  • Myelodysplastic Syndrome

  • Acute Leukemia

Biomarkers

  • TIMP Metallopeptidase Inhibitor 1

  • Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Epsilon

Drug/Treatment

  • Erythropoietin

  • Vidaza

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved